Literature DB >> 20388525

Pharmacological potential of RNAi--focus on miRNA.

Alexander Pfeifer1, Holger Lehmann.   

Abstract

RNA interference (RNAi) is a cellular process that is widely used as a research tool to control the expression of specific genes and has the potential as a therapeutic strategy for many diseases. MicroRNAs (miRNAs) and short interfering RNAs (siRNAs) are the two principal categories of small RNAs that induce RNAi in a broad spectrum of eukaryotic organisms including human cells. miRNAs have an enormous capacity to regulate multiple genes and the expression of approximately 30% of the human genes is affected by these non-coding RNAs. Because many miRNAs are specifically expressed during disease, miRNAs are interesting tools for pharmacology and understanding the function of specific miRNAs will help to identify novel drug targets. Furthermore, miRNA-based diagnostics as well as therapeutic interventions are being developed for clinical applications. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388525     DOI: 10.1016/j.pharmthera.2010.03.006

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  9 in total

1.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

2.  Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery.

Authors:  Rubén Cereijo; Siri D Taxerås; Irene Piquer-Garcia; Silvia Pellitero; Eva Martínez; Jordi Tarascó; Pau Moreno; José Balibrea; Manel Puig-Domingo; David Jiménez-Pavón; Carles Lerin; Francesc Villarroya; David Sánchez-Infantes
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

3.  miR-375 is cold exposure sensitive and drives thermogenesis in visceral adipose tissue derived stem cells.

Authors:  Claudine Seeliger; Tanja Krauss; Julius Honecker; Laura Aline Mengel; Lise Buekens; Alberto Mesas-Fernández; Thomas Skurk; Melina Claussnitzer; Hans Hauner
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

4.  Dystrophin Orchestrates the Epigenetic Profile of Muscle Cells Via miRNAs.

Authors:  April K Marrone; Halyna R Shcherbata
Journal:  Front Genet       Date:  2011-09-13       Impact factor: 4.599

5.  Gene-microRNA network module analysis for ovarian cancer.

Authors:  Shuqin Zhang; Michael K Ng
Journal:  BMC Syst Biol       Date:  2016-12-23

6.  miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit.

Authors:  Yong Chen; Franziska Siegel; Stefanie Kipschull; Bodo Haas; Holger Fröhlich; Gunter Meister; Alexander Pfeifer
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Different microRNA profiles in chronic epilepsy versus acute seizure mouse models.

Authors:  Anita Kretschmann; Benedicte Danis; Lidija Andonovic; Khalid Abnaof; Marijke van Rikxoort; Franziska Siegel; Manuela Mazzuferi; Patrice Godard; Etienne Hanon; Holger Fröhlich; Rafal M Kaminski; Patrik Foerch; Alexander Pfeifer
Journal:  J Mol Neurosci       Date:  2014-07-31       Impact factor: 3.444

8.  Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity.

Authors:  Yong Chen; Joschka J Buyel; Mark J W Hanssen; Franziska Siegel; Ruping Pan; Jennifer Naumann; Michael Schell; Anouk van der Lans; Christian Schlein; Holger Froehlich; Joerg Heeren; Kirsi A Virtanen; Wouter van Marken Lichtenbelt; Alexander Pfeifer
Journal:  Nat Commun       Date:  2016-04-27       Impact factor: 14.919

9.  Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis - Influence on microglial function.

Authors:  Bénédicte Danis; Marijke van Rikxoort; Anita Kretschmann; Jiong Zhang; Patrice Godard; Lidija Andonovic; Franziska Siegel; Pitt Niehusmann; Etienne Hanon; Daniel Delev; Marec von Lehe; Rafal M Kaminski; Alexander Pfeifer; Patrik Foerch
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.